
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $7.9B | $8.4B | $9.3B | $10.7B | $12B | |
Revenue Growth (YoY) | 5.29% | 6.42% | 10.71% | 15.15% | 12.36% | |
Cost of Revenues | $3.7B | $3.9B | $4.3B | $4.9B | $5.4B | |
Gross Profit | $4.2B | $4.5B | $5B | $5.7B | $6.6B | |
Gross Profit Margin | 53.46% | 53.37% | 53.51% | 53.85% | 54.77% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1B | $1.2B | $1.5B | $1.3B | $1.2B | |
Other Inc / (Exp) | -$31.2M | -$6.3M | $32M | $2M | $27M | |
Operating Expenses | $3.4B | $3.8B | $4.5B | $4.7B | $5.2B | |
Operating Income | $754.4M | $685.2M | $447M | $1B | $1.4B | |
Net Interest Expenses | $60.7M | $74.8M | $111M | $162M | $178M | |
EBT. Incl. Unusual Items | $662.4M | $604M | $368M | $854M | $1.2B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $53.5M | $137.5M | $97M | $248M | $284M | |
Net Income to Company | $609M | $466.6M | $271M | $606M | $935M | |
Minority Interest in Earnings | -- | $163K | $576K | -- | -- | |
Net Income to Common Excl Extra Items | $609M | $466.7M | $271M | $606M | $935M | |
Basic EPS (Cont. Ops) | $4.40 | $3.46 | $2.04 | $4.61 | $7.28 | |
Diluted EPS (Cont. Ops) | $4.37 | $3.44 | $2.03 | $4.59 | $7.25 | |
Weighted Average Basic Share | $137.7M | $134.1M | $132.2M | $130.4M | $127.8M | |
Weighted Average Diluted Share | $138.7M | $134.9M | $132.7M | $130.8M | $128.3M | |
EBITDA | $803.1M | $820M | $649M | $1.2B | $1.6B | |
EBIT | $718.8M | $674.2M | $484M | $1B | $1.4B | |
Revenue (Reported) | $7.9B | $8.4B | $9.3B | $10.7B | $12B | |
Operating Income (Reported) | $754.4M | $685.2M | $447M | $1B | $1.4B | |
Operating Income (Adjusted) | $718.8M | $674.2M | $484M | $1B | $1.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2B | $2.2B | $2.4B | $2.8B | $3B | |
Revenue Growth (YoY) | 0.49% | 13.08% | 8.73% | 13.89% | 7.33% | |
Cost of Revenues | $899.3M | $1.1B | $1.1B | $1.3B | $1.4B | |
Gross Profit | $1.1B | $1.2B | $1.3B | $1.5B | $1.6B | |
Gross Profit Margin | 54.57% | 52.66% | 53.6% | 54.7% | 53.61% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $291.5M | $332.4M | $563.9M | $365.8M | $349.7M | |
Other Inc / (Exp) | -$5.7M | -$4.4M | -$4.6M | -$21M | -$986K | |
Operating Expenses | $909M | $1B | $1.3B | $1.3B | $1.3B | |
Operating Income | $171M | $148.3M | -$42.8M | $265M | $275M | |
Net Interest Expenses | $15M | $19.2M | $27.5M | $24.1M | $31.1M | |
EBT. Incl. Unusual Items | $150.2M | $124.7M | -$74.8M | $220M | $242.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$48.9M | $33.9M | -$6.3M | $91.7M | $50.2M | |
Net Income to Company | $199.2M | $90.8M | -$68.6M | $128.3M | $192.7M | |
Minority Interest in Earnings | -- | $78K | -$74K | -- | -- | |
Net Income to Common Excl Extra Items | $199.2M | $90.9M | -$69.2M | $128.3M | $192.7M | |
Basic EPS (Cont. Ops) | $1.45 | $0.69 | -$0.51 | $0.98 | $1.53 | |
Diluted EPS (Cont. Ops) | $1.44 | $0.68 | -$0.51 | $0.97 | $1.52 | |
Weighted Average Basic Share | $137M | $132.6M | $131.8M | $129.5M | $125.8M | |
Weighted Average Diluted Share | $138M | $133.5M | $132.4M | $130.1M | $126.4M | |
EBITDA | $185.6M | $183.6M | $4.8M | $308.7M | $331.7M | |
EBIT | $164.2M | $142.8M | -$39M | $268.6M | $290.1M | |
Revenue (Reported) | $2B | $2.2B | $2.4B | $2.8B | $3B | |
Operating Income (Reported) | $171M | $148.3M | -$42.8M | $265M | $275M | |
Operating Income (Adjusted) | $164.2M | $142.8M | -$39M | $268.6M | $290.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $7.9B | $8.4B | $9.3B | $10.7B | $12B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $3.7B | $3.9B | $4.3B | $4.9B | $5.4B | |
Gross Profit | $4.2B | $4.5B | $5B | $5.7B | $6.6B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1B | $1.2B | $1.5B | $1.3B | $1.2B | |
Other Inc / (Exp) | -$31.2M | -$6.3M | $32M | $2M | $27M | |
Operating Expenses | $3.4B | $3.8B | $4.5B | $4.7B | $5.2B | |
Operating Income | $754.4M | $685.2M | $447M | $1B | $1.4B | |
Net Interest Expenses | $60.7M | $74.8M | $111M | $162M | $178M | |
EBT. Incl. Unusual Items | $662.4M | $604M | $368M | $854M | $1.2B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $53.5M | $137.5M | $97M | $248M | $284M | |
Net Income to Company | $609M | $466.6M | $271M | $606M | $935M | |
Minority Interest in Earnings | -- | $163K | $650K | -- | -- | |
Net Income to Common Excl Extra Items | $609M | $466.7M | $271M | $606M | $935M | |
Basic EPS (Cont. Ops) | $4.40 | $3.47 | $2.04 | $4.60 | $7.28 | |
Diluted EPS (Cont. Ops) | $4.37 | $3.44 | $2.03 | $4.59 | $7.25 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $803.1M | $820M | $649M | $1.2B | $1.6B | |
EBIT | $718.8M | $674.2M | $484M | $1B | $1.4B | |
Revenue (Reported) | $7.9B | $8.4B | $9.3B | $10.7B | $12B | |
Operating Income (Reported) | $754.4M | $685.2M | $447M | $1B | $1.4B | |
Operating Income (Adjusted) | $718.8M | $674.2M | $484M | $1B | $1.4B |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $8.4B | $9.3B | $10.7B | $12B | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $3.9B | $4.3B | $4.9B | $5.4B | -- | |
Gross Profit | $4.5B | $5B | $5.7B | $6.6B | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.2B | $1.5B | $1.3B | $1.2B | -- | |
Other Inc / (Exp) | -$6.3M | $32M | $2M | $27M | -- | |
Operating Expenses | $3.8B | $4.5B | $4.7B | $5.2B | -- | |
Operating Income | $685.2M | $447M | $1B | $1.4B | -- | |
Net Interest Expenses | $74.8M | $111M | $162M | $178M | -- | |
EBT. Incl. Unusual Items | $604M | $368M | $854M | $1.2B | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $137.5M | $97M | $248M | $284M | -- | |
Net Income to Company | $466.6M | $271M | $606M | $935M | -- | |
Minority Interest in Earnings | $163K | $576K | -- | -- | -- | |
Net Income to Common Excl Extra Items | $466.7M | $271M | $606M | $935M | -- | |
Basic EPS (Cont. Ops) | $3.47 | $2.04 | $4.60 | $7.28 | -- | |
Diluted EPS (Cont. Ops) | $3.44 | $2.03 | $4.59 | $7.25 | -- | |
Weighted Average Basic Share | $536.6M | $528.7M | $521.5M | $511M | -- | |
Weighted Average Diluted Share | $539.4M | $530.9M | $523.2M | $513.1M | -- | |
EBITDA | $820M | $649M | $1.2B | $1.6B | -- | |
EBIT | $674.2M | $484M | $1B | $1.4B | -- | |
Revenue (Reported) | $8.4B | $9.3B | $10.7B | $12B | -- | |
Operating Income (Reported) | $685.2M | $447M | $1B | $1.4B | -- | |
Operating Income (Adjusted) | $674.2M | $484M | $1B | $1.4B | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $991M | $695.9M | $404.9M | $554M | $885M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $375.4M | $465.3M | $551.7M | $700M | $781M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $233.3M | $126.8M | -- | -- | -- | |
Other Current Assets | -- | -- | $108.4M | $138M | $157M | |
Total Current Assets | $2.6B | $2.4B | $2.3B | $2.7B | $3.3B | |
Property Plant And Equipment | $444M | $429.5M | $383M | $362M | $355M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1.6B | $2B | $2.3B | $2.3B | $2.4B | |
Other Intangibles | $307.1M | $646.7M | $685.6M | $601M | $563M | |
Other Long-Term Assets | $467.3M | $385.2M | $222.4M | $234M | $286M | |
Total Assets | $5.5B | $6B | $6.6B | $6.6B | $7.3B | |
Accounts Payable | $371.7M | $539.5M | $597.8M | $653M | $693M | |
Accrued Expenses | $295.2M | $363.1M | $718.8M | $34M | $49M | |
Current Portion Of Long-Term Debt | $77.9M | $68.4M | $41.3M | $62M | $83M | |
Current Portion Of Capital Lease Obligations | $55M | $52.3M | $51.2M | $43M | $41M | |
Other Current Liabilities | $49.8M | $45.2M | $23.7M | $14M | $15M | |
Total Current Liabilities | $1.3B | $1.5B | $1.9B | $1.7B | $1.8B | |
Long-Term Debt | $2.3B | $2.7B | $2.8B | $3.4B | $3.9B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.4B | $5B | $5.6B | $5.5B | $6.3B | |
Common Stock | $1.6M | $1.6M | $1.7M | $2M | $2M | |
Other Common Equity Adj | -$29.8M | $8.6M | $29.3M | $10M | -$29M | |
Common Equity | $1.1B | $1B | $992M | $1B | $1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | $651K | -- | -- | -- | |
Total Equity | $1.1B | $1B | $992M | $1B | $1B | |
Total Liabilities and Equity | $5.5B | $6B | $6.6B | $6.6B | $7.3B | |
Cash and Short Terms | $991M | $695.9M | $404.9M | $554M | $885M | |
Total Debt | $2.4B | $2.8B | $2.8B | $3.4B | $4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $991M | $695.9M | $404.9M | $554M | $885M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $375.4M | $465.3M | $551.7M | $700M | $781M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $233.3M | $126.8M | -- | -- | -- | |
Other Current Assets | -- | -- | $108.4M | $138M | $157M | |
Total Current Assets | $2.6B | $2.4B | $2.3B | $2.7B | $3.3B | |
Property Plant And Equipment | $444M | $429.5M | $383M | $362M | $355M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1.6B | $2B | $2.3B | $2.3B | $2.4B | |
Other Intangibles | $307.1M | $646.7M | $685.6M | $601M | $563M | |
Other Long-Term Assets | $467.3M | $385.2M | $222.4M | $234M | $286M | |
Total Assets | $5.5B | $6B | $6.6B | $6.6B | $7.3B | |
Accounts Payable | $371.7M | $539.5M | $597.8M | $653M | $693M | |
Accrued Expenses | $295.2M | $363.1M | $718.8M | $34M | $49M | |
Current Portion Of Long-Term Debt | $77.9M | $68.4M | $41.3M | $62M | $83M | |
Current Portion Of Capital Lease Obligations | $55M | $52.3M | $51.2M | $43M | $41M | |
Other Current Liabilities | $49.8M | $45.2M | $23.7M | $14M | $15M | |
Total Current Liabilities | $1.3B | $1.5B | $1.9B | $1.7B | $1.8B | |
Long-Term Debt | $2.3B | $2.7B | $2.8B | $3.4B | $3.9B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.4B | $5B | $5.6B | $5.5B | $6.3B | |
Common Stock | $1.6M | $1.6M | $1.7M | $2M | $2M | |
Other Common Equity Adj | -$29.8M | $8.6M | $29.3M | $10M | -$29M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | $651K | -- | -- | -- | |
Total Equity | $1.1B | $1B | $992M | $1B | $1B | |
Total Liabilities and Equity | $5.5B | $6B | $6.6B | $6.6B | $7.3B | |
Cash and Short Terms | $991M | $695.9M | $404.9M | $554M | $885M | |
Total Debt | $2.4B | $2.8B | $2.8B | $3.4B | $4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $609M | $466.6M | $271M | $606M | $935M | |
Depreciation & Amoritzation | $84.3M | $145.7M | $165M | $164M | $165M | |
Stock-Based Compensation | $59.8M | $69.8M | $80M | $95M | $94M | |
Change in Accounts Receivable | $47.1M | -$154.7M | -$130M | -$270M | -$206M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $718.7M | $736.5M | $603M | $259M | $1B | |
Capital Expenditures | $87.2M | $80M | $76M | $67M | $98M | |
Cash Acquisitions | -$74.2M | -$780.3M | -$387M | -- | -$83M | |
Cash From Investing | -$158.3M | -$867.7M | -$468M | -$91M | -$218M | |
Dividends Paid (Ex Special Dividend) | -$181.1M | -$209.1M | -$236M | -$254M | -$268M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $691.5M | $547M | $415M | $1.1B | $844M | |
Long-Term Debt Repaid | -$527.9M | -$112.3M | -$417M | -$541M | -$262M | |
Repurchase of Common Stock | -$313.4M | -$418.9M | -$224M | -$404M | -$812M | |
Other Financing Activities | -$11.7M | -- | -- | -- | -- | |
Cash From Financing | -$311.3M | -$163.8M | -$426M | -$19M | -$460M | |
Beginning Cash (CF) | $741.9M | $991M | $696M | $405M | $554M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $249.1M | -$295M | -$291M | $149M | $331M | |
Ending Cash (CF) | $991M | $695.9M | $405M | $554M | $885M | |
Levered Free Cash Flow | $631.5M | $656.6M | $527M | $192M | $911M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $92.1M | $138.1M | $161.4M | $165.2M | -- | |
Depreciation & Amoritzation | $27.7M | $40.1M | $41.8M | $41.1M | -- | |
Stock-Based Compensation | $12.4M | $13.7M | $17.7M | $19.9M | -- | |
Change in Accounts Receivable | -$220.1M | -$205.4M | -$325.4M | -$217.1M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$10.7M | -$45.6M | -$71.5M | $52.1M | -- | |
Capital Expenditures | $9M | $13.7M | $10.5M | $32.4M | -- | |
Cash Acquisitions | -$665.6M | -- | -$406K | -$92.5M | -- | |
Cash From Investing | -$676.6M | -$13.7M | -$15.1M | -$127.3M | -- | |
Dividends Paid (Ex Special Dividend) | -$51.6M | -$58.9M | -$63M | -$66.4M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $547M | -- | $75M | -- | -- | |
Long-Term Debt Repaid | -$61M | -$17.1M | -$10.3M | -$10.3M | -- | |
Repurchase of Common Stock | -$123.8M | -$73.4M | -$128.4M | -$116.3M | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $318.2M | -$138.7M | -$108.6M | -$181.4M | -- | |
Beginning Cash (CF) | $991M | $695.9M | $404.9M | $554.3M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$369.1M | -$198.1M | -$195.2M | -$256.6M | -- | |
Ending Cash (CF) | $621.9M | $497.8M | $209.6M | $297.7M | -- | |
Levered Free Cash Flow | -$19.7M | -$59.4M | -$82M | $19.7M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $609M | $466.6M | $271M | $606M | $935M | |
Depreciation & Amoritzation | $84.3M | $145.7M | $165M | $164M | $165M | |
Stock-Based Compensation | $59.8M | $69.8M | $80M | $95M | $94M | |
Change in Accounts Receivable | $47.1M | -$154.7M | -$130M | -$270M | -$206M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $718.7M | $736.5M | $603M | $259M | $1B | |
Capital Expenditures | $87.2M | $80M | $76M | $67M | $98M | |
Cash Acquisitions | -$74.2M | -$780.3M | -$387M | -- | -$83M | |
Cash From Investing | -$158.3M | -$867.7M | -$468M | -$91M | -$218M | |
Dividends Paid (Ex Special Dividend) | -$181.1M | -$209.1M | -$236M | -$254M | -$268M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $691.5M | $547M | $415M | $1.1B | $844M | |
Long-Term Debt Repaid | -$527.9M | -$112.3M | -$417M | -$541M | -$262M | |
Repurchase of Common Stock | -$313.4M | -$418.9M | -$224M | -$404M | -$812M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$311.3M | -$163.8M | -$426M | -$19M | -$460M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $249.1M | -$295M | -$291M | $149M | $331M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $631.5M | $656.6M | $527M | $192M | $911M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $92.1M | $138.1M | $161.4M | $165.2M | -- | |
Depreciation & Amoritzation | $27.7M | $40.1M | $41.8M | $41.1M | -- | |
Stock-Based Compensation | $12.4M | $13.7M | $17.7M | $19.9M | -- | |
Change in Accounts Receivable | -$220.1M | -$205.4M | -$325.4M | -$217.1M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$10.7M | -$45.6M | -$71.5M | $52.1M | -- | |
Capital Expenditures | $9M | $13.7M | $10.5M | $32.4M | -- | |
Cash Acquisitions | -$665.6M | -- | -$406K | -$92.5M | -- | |
Cash From Investing | -$676.6M | -$13.7M | -$15.1M | -$127.3M | -- | |
Dividends Paid (Ex Special Dividend) | -$51.6M | -$58.9M | -$63M | -$66.4M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $547M | -- | $75M | -- | -- | |
Long-Term Debt Repaid | -$61M | -$17.1M | -$10.3M | -$10.3M | -- | |
Repurchase of Common Stock | -$123.8M | -$73.4M | -$128.4M | -$116.3M | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $318.2M | -$138.7M | -$108.6M | -$181.4M | -- | |
Beginning Cash (CF) | $991M | $695.9M | $404.9M | $554.3M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$369.1M | -$198.1M | -$195.2M | -$256.6M | -- | |
Ending Cash (CF) | $621.9M | $497.8M | $209.6M | $297.7M | -- | |
Levered Free Cash Flow | -$19.7M | -$59.4M | -$82M | $19.7M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.